Scientists Puzzled by Giant Ancient Life Forms
In a new, yet-to-be-peer-reviewed paper, scientists from the University of Edinburgh in Scotland argue that the massive and mysterious tubelike fossils known as "prototaxites" deserve their own life form classification because, basically, they're too weird to belong to any other.
Since their discovery in the 1800s, prototaxites have long been a head-scratcher and a point of contention for scientists who to this day cannot figure out their nature. Fossils of this bizarre organism, which lived some 400 million years ago, were initially thought to be the remains of rotted trees, complete with the fungi that assisted their decomposition inside them. In 1872, however, a ticked-off Canadian scientist named William Carruthers trashed that concept and suggested, against scientific convention, that the name prototaxites, which translates to "first yew," be changed to "nematophycus," which means "stringy algae."
Fast forward to 2007, and Stanford botanist Kevin Boyce declared, after analyzing the carbon isotypes found within a prototaxites fossil, that the strange monstrosities were some kind of fungus because they seemed to have gotten carbon from other organisms the way fungi do. Now, Edinburgh's Corentin Loron and his team are pouring water on that hypothesis as well — and suggesting, provocatively, that prototaxites don't belong to any other known lineage of organism and thus deserve their own.
To reach that conclusion, Loron and his colleagues analyzed the chemical makeup of Prototaxites taiti, a type of prototaxites found in Scotland that was, unlike its cousins, only a few centimeters tall. Fungi were abundant in the area where p. taiti was found, so the scientists were able to compare the composition of those fossilized fungi to that of the prototaxites fossils.
As they discovered, the cellular composition of p. taiti was vastly different from the fungi that grew alongside it — and indeed, was distinct from all known fungi, extinct or otherwise. Specifically, the prototaxites sample did not contain any chitin, a polymer that makes up fungal cell walls, which to their minds meant that it wasn't a fungus at all. Its anatomy was also "fundamentally distinct from all known extant or extinct fungi," the researchers wrote in their paper, which added to their contention that prototaxites should be granted their own lineage.
Boyce, the botanist who insisted that prototaxites are a fungus nearly 20 years ago, admitted in an interview with New Scientist about the new research that with the information that's been uncovered in the intervening years, "there is no good place" for the organism in the fungal lineage.
"Maybe it is a fungus," he told the magazine, "but whether a fungus or something else entirely, it represents a novel experiment with complex multicellularity that is now extinct and does not share a multicellular common ancestor with anything alive today."
Notably, scientists still don't know why prototaxites went extinct. This new research provides another clue about this bizarre and long-dead organism — and deepens the mystery, too.
More on weird life: Scientists Modified Genes In Mice to Give Them Traits of Woolly Mammoths, and the Results Are Frankly Adorable
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 hours ago
- Yahoo
Scientists stunned by 'remarkable' reappearance of species thought to be extinct: 'One of the most historic comebacks ever'
Scientists stunned by 'remarkable' reappearance of species thought to be extinct: 'One of the most historic comebacks ever' For the first time in centuries — and arguably millennia — it's a good time to be the leaf-toed gecko in the Galápagos. Prior to 2019, the minuscule, centimeters-long species had only been found on the islands in their 5,000-year-old fossil records. But after conservation efforts successfully eradicated invasive, predatory rats, live specimens were found in both 2019 and 2021, New Scientist reported. Specifically, the gecko was found on Rábida Island, which was part of a group of 11 Galápagos Islands that benefited from a restoration and rewilding project in 2011. The nonprofit group Island Conservation worked in tandem with Galápagos National Park, the Charles Darwin Foundation, and The Raptor Center to eliminate the invasive rat population by distributing poisoned bait from helicopters. And it worked astonishingly well. The rats were confirmed as removed from Rábida just a year later, and several species were observed to be "immediately bouncing back," as New Scientist put it. One of these was the leaf-toed gecko. "We conducted extensive monitoring prior to the removal of invasive rats and they weren't detected at all," Paula Castaño of Island Conservation said. "We believe a small population held on all those years and then, without invasive predators, it finally had the opportunity to recover and grow its population. You can call it one of the most historic comebacks ever or just a long-overdue reappearance." The success underscores just how harmful even a single invasive species can be to a local ecosystem. From outcompeting native species for resources to demolishing prey species, invasive animals can wreak major havoc on an environment (and its local economy, too). In many cases, these invasive animals arrive in new environments via human activity. Accidental transport — like in the case of the tiny New Zealand mud snail — and travel, trade, and illegal smuggling have all resulted in invasive species infiltrating new environments. Fortunately, in Rábida's case, conservation efforts worked in time to reverse the damage done by the invasive rats. "We found the 'extinct' gecko, rediscovered a snail last seen in 1906, as well as two other snail species being recorded on the island for the first time ever that are still being identified, and Galápagos hawks have returned and are thriving," Castaño said. "Nature is remarkable — allow it an opportunity to thrive and it comes roaring back." Do you think America does a good job of protecting its natural beauty? Definitely Only in some areas No way I'm not sure Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword
Yahoo
a day ago
- Yahoo
Surf Bio Announces Peer-Reviewed Publication Demonstrating Feasibility of Subcutaneous Delivery of Ultra-Concentrated Biologics
Research conducted by Stanford University and published in Science Translational Medicine shows successful injection of protein formulations exceeding 500 mg/mL PALO ALTO, Calif., Aug. 20, 2025 /PRNewswire/ -- Surf Bio, a biopharmaceutical company transforming the delivery of antibodies and biologics, announced today that a peer-reviewed study conducted by researchers at Stanford University and published in Science Translational Medicine has demonstrated the feasibility of reformulating biologics for subcutaneous delivery at ultra-high concentrations. The study's lead author, Carolyn Jons, Ph.D., and collaborators reported that spray-dried microparticle formulations surpassed 500 mg/mL and were delivered through a standard 27-gauge needle at clinically relevant forces, marking a potential breakthrough in expanding access to infusion-only therapies. The paper, entitled, "Glassy Surfactants Enable Ultra-High Concentration Biologic Therapeutics," may be accessed via the following URL: "The research addresses one of the most persistent challenges in drug delivery: how to administer high-dose biologic therapies without the need for intravenous infusion," stated Dr. Jons. "Many existing protein-based therapies require hospital or clinic-based infusions due to their large volume, instability, or reconstitution requirements. This study describes a spray-drying process that converts protein formulations into microparticles suspended in a non-solvent liquid carrier, resulting in a stable, ready-to-inject solution that meets the viscosity and force thresholds for subcutaneous administration." "This research provides a critical foundation for our work at Surf Bio and highlights the significant potential of our SnapShot™ technology," said Bryan Mazlish, CEO of Surf Bio. "We're leveraging this licensed platform to help unlock subcutaneous administration for therapies that have historically required IV infusion. Our goal is to translate this innovation into ready-to-inject, patient-friendly formulations that reduce burden on the healthcare system while enabling self-administration at home." Importantly, the platform utilizes a polymer excipient that improves stability during spray drying and enhances the injectability of the final formulation. In preclinical models, these microparticles were shown to maintain protein activity and structure, achieving doses well beyond those currently accessible with drug products approved for subcutaneous delivery. The technology does not require any specialized delivery device and can be used with commercially available autoinjectors and standard fill-finish processes. About Surf Bio:Surf Bio is a biopharmaceutical company transforming the delivery of antibodies and biologics via its SnapShot™ technology platform. Powered by the Company's proprietary polymer, SnapShot enables the development of ultra-high concentration formulations of monoclonal antibodies (mAbs) and biologics that can be administered using a single, standard autoinjector shot. To date, in-vitro and in-vivo safety and efficacy data have demonstrated that SnapShot enables drug developers to produce very high concentration, subcutaneous formulations of novel mAbs and biologics. Surf Bio was launched by the founders of Bigfoot Biomedical and AGC to commercialize a breakthrough drug delivery technology developed in the Appel lab at Stanford University. For more information about Surf Bio, visit Contact for Surf Bio:Tiberend Strategic Advisors, Reissereiss@ View original content to download multimedia: SOURCE Surf Bio, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Vegetarianism associated with decreased cancer risk
Cancer is the second leading cause of death globally, accounting for 1 in 6 deaths worldwide in 2018, according to the World Health Organization. Cancer is caused by both genetic and environmental factors, which vary depending on cancer type. Diet is known to be a major risk factor for multiple cancers, with processed and red meat being a risk factor for bowel cancer. Previous studies have explored the association between vegetarianism and multiple common cancers, but associations with less common cancers have yet to be explored, and in research published in The American Journal of Clinical Nutrition, Gary Fraser and colleagues used cohort study data from The Adventist Health Study-2 (AHS-2) to assess the relationship between vegetarianism and risk of different uncommon and common cancer types. The study found that vegetarians had a 12% lower risk of developing cancer overall compared to non-vegetarians. To observe the effects of diet and the odds of developing cancer, the study collected baseline data of participants from the AHS-2. This cohort study recruited more than 95,000 US and Canadian participants between 2002 and 2007, all of whom were volunteer members of the Seventh-day Adventist church. Dietary habits were obtained from a validated food frequency questionnaire. Vegetarians included those categorised as vegans (who avoided all animal products, consuming fewer than one such product per month), lacto-ovo-vegetarians (who avoided meat and fish but consumed eggs/dairy once or more per month), and pesco-vegetarians (who avoided meat but consumed eggs/dairy/fish once or more per month). Cancer diagnosis (identified using the International Classification of Diseases version 10 and International Classification of Diseases, Oncology codes) was obtained by matching the AHS-2 data to cancer registries, with follow-up lasting from 2010 to 2013, depending on the US state and Canadian province/territory. In total, 79,468 participants were included in the study. Compared to non-vegetarians, vegetarians had a 12% lower risk of developing cancer overall. Vegetarians were also shown to have decreased risk of bowel cancer development, with a 45% lower risk of developing stomach cancer, a 20% lower risk of developing colon cancer, and a 21% lower risk of developing colorectal cancer. Other than bowel cancers, vegetarians had a lower risk of lymphoma and lymphoproliferative cancers compared to non-vegetarians, both with a 25% decreased risk. The study by Fraser and colleagues provides further evidence of vegetarianism being a protective factor against bowel cancers, and also provides new evidence for vegetarianism being a protective factor against lymphoproliferative cancers. The study therefore provides an incentive to explore what aspects of vegetarianism protect against these cancers specifically. However, it is important to note that information on dietary habits was taken at the beginning of the study, which was subject to change during follow-up. GlobalData epidemiologists forecast that in the 16 major markets (16MM: Australia, Brazil, Canada, China, France, Germany, Italy, Japan, India, Mexico, Russia, South Africa, South Korea, Spain, the UK and the US), five-year diagnosed prevalent cases of colorectal cancer in men and women aged 18 years and over will increase from 4.6 million in 2025 to 5.4 million in 2031. "Vegetarianism associated with decreased cancer risk" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data